Seer, Inc. (SEER) — Stock Valuation & Research

Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research…

SEER key statistics

Explore SEER's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.